This Merck-sponsored meeting, MS Medical Grand Rounds: Novel Perspectives on MS Disease Management, is a discussion-based meeting of one-hour duration that uses a patient case study format, similar to a hospital grand rounds meeting. The meeting will focus on cognitive decline and uncovering PIRA, how targeting the BTK pathway may be beneficial to patients, and managing progression with long-term treatment using IRT.
PROGRAM
FACULTY
Dr. Wallace Brownlee - Chair
Consultant Neurologist and Clinical Lead for the Multiple Sclerosis Service at the National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, University College London Hospitals
London, United Kingdom
Prof. Celia Oreja-Guevara
Vice Chair of Neurology, Head of the Multiple Sclerosis Centre and Associate Professor of Neurology at the University Hospital San Carlos
Madrid, Spain
Prof. Klaus Schmierer
Professor of Neurology, the Blizard Institute, Queen Mary University of London and Consultant Neurologist (Royal London Hospital, Barts Health NHS Trust)
London, United Kingdom
ASK A QUESTION
If you have a question for the speakers, relating to region-specific challenges or the influence of risk factors in MS management, please submit via the link below.
Deadline: November 27, 2023
TARGET AUDIENCE
- Specialists
- Neurologists
- Practitioners
- Researchers in the field of MS
REGISTRATION
This Medical program is funded and organized by Merck. The materials shown are intended for discussion purposes and must not be considered medical advice from a healthcare professional. It is not intended to promote the use of any products. This program is intended for healthcare professionals only but not for US healthcare professionals. Scientific opinions presented therein do not necessarily represent the position of Merck. Treatment decisions are made on an individual basis by the responsible physician and do not necessarily reflect the position of Merck.